$13.01
Above FV▼ -51.7% against the close used
Model range $5.45 – $19.32
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear$5.45Fair value$13.01Bull$19.32
FairClose
52-week traded range
52W low $15.9152W high $29.66
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
Edgewell Personal Care closed at $26.93, 107.0% above the consensus fair value of $13.01 drawn from 9 valuation models.
Financial DNA score 39/100 — Average. P/E of 50.8x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
$16.19
-39.9%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
$19.32
-28.2%
√(22.5 × EPS × BVPS)
EPS=0.53, BVPS=31.31 · outside Graham range (P/E 50.8, P/B 0.9) — asset-light, treat as a rough floor
P/E Fair Value
$10.60
-60.6%
EPS × 20x (sector P/E)
EPS=0.53, Sector P/E=20x
Peter Lynch (PEG)
$5.80
-78.4%
EPS × Growth% (PEG = 1 is fair)
EPS=0.53, g=11%
EV/EBITDA
$14.53
-46.0%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=185.4M
Dividend Discount (DDM)
$7.66
-71.6%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=0.6, r=10%, g=2%
Book Value (P/B)
$5.45
-79.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=31.31, ROE=1.7%, g=3%, r=10%
Reverse DCF
$26.93
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 19.7% | Historical: -11%
Margin of Safety
$11.53
-57.2%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=15.37, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.